78 FR 145 pg. 45592 - DeltaPoint Capital IV, LP;
Type: NOTICEVolume: 78Number: 145Page: 45592
Page: 45592Docket number: [License No. 02/02-0662]
FR document: [FR Doc. 2013-17945 Filed 7-26-13; 8:45 am]
Agency: Small Business Administration
Official PDF Version: PDF Version
[top]
SMALL BUSINESS ADMINISTRATION
[License No. 02/02-0662]
DeltaPoint Capital IV, LP;
Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest
Notice is hereby given that DeltaPoint Capital IV, L.P., 45 East Avenue, 6th Floor, Rochester, NY 14604, Federal Licensees under the Small Business Investment Act of 1958, as amended ("the Act"), in connection with the financing of a small concern, has sought an exemption under Section 312 of the Act and Section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration ("SBA") Rules and Regulations (13 CFR 107.730). DeltaPoint Capital IV, L.P. provided financing to BioMaxx, Inc., 1 Fishers Road, Suite 160, Pittsford, NY 14534. The financing was contemplated for working capital.
The financing is brought within the purview of § 107.730(a)(1) of the Regulations because DeltaPoint Capital IV (New York), L.P., an Associate of DeltaPoint Capital IV, L.P., owns more than ten percent of BioMaxx, Inc.
Therefore, this transaction is considered a financing of an Associate requiring an exemption. Notice is hereby given that any interested person may submit written comments on the transaction within fifteen days of the date of this publication to the Acting Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street SW., Washington, DC 20416.
Dated: July 15, 2013.
Pravina Raghavan,
Acting Associate Administrator for Investment & Innovation.
[FR Doc. 2013-17945 Filed 7-26-13; 8:45 am]
BILLING CODE 8025-01-M